Use of multilocus variable-number tandem repeat analysis (MLVA) in eight European countries, 2012.

B A Lindstedt (1) , M Torpdahl (2) , Gilles Vergnaud (3, 4) , S Le Hello (5) , F X Weill (5) , E Tietze (6) , B Malorny (7) , D M Prendergast (8) , E Ní Ghallchoir (8) , R F Lista (9) , L M Schouls (10) , R Söderlund (11) , S Börjesson (11) , S Åkerström (11)

1 NIPH - Norwegian Institute of Public Health [Oslo]
2 Statens Serum Institut [Copenhagen]
3 IGM - Institut de génétique et microbiologie [Orsay]
4 DGA - Direction générale de l'armement [Bagneux]
5 CNR-ESS - Centre National de Référence - National Reference Center Escherichia coli, Shigella et Salmonella
6 RKI - Robert Koch Institute [Berlin]
7 Federal Institute for Risk Assesment
8 Central Veterinary Research Laboratory
9 Health Corps Italian Army
10 RIVM - National Institute for Public Health and the Environment [Bilthoven]
11 SVA - National Veterinary Institute [Uppsala]

Genotyping of important medical or veterinary prokaryotes has become a very important tool during the last decades. Rapid development of fragment-separation and sequencing technologies has made many new genotyping strategies possible. Among these new methods is multilocus variable-number tandem repeat analysis (MLVA). Here we present an update on the use of MLVA in eight European countries (Denmark, France, Germany, Ireland, Italy, the Netherlands, Norway and Sweden). Researchers in Europe have been active in developing and implementing a large array of different assays. MLVA has been used as a typing tool in several contexts, from aiding in resolving outbreaks of foodborne bacteria to typing organisms that may pose a bioterrorist threat, as well as in scientific studies.

Domains: Life Sciences [q-bio]

B A Lindstedt, M Torpdahl, Gilles Vergnaud, S Le Hello, F X Weill, et al.. Use of multilocus variable-number tandem repeat analysis (MLVA) in eight European countries, 2012.. Eurosurveillance, 2012, 18 (4), pp.20385. ⟨10.2807/ese.18.04.20385-en⟩. ⟨pasteur-01111429⟩